Background Mitral valve repair (MVr) is the gold standard treatment for degenerative mitral regurgitation, yet there is ...

Veeva CTMS is part of Veeva Clinical Platform , the most complete and highest-quality platform for faster and more efficient trials. Learn more at Veeva R&D and Quality Summit, Europe . Life sciences ...

Biopharmas use leading CTMS for improved trial efficiency and collaboration BARCELONA, Spain, Jan. 29, 2025 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today announced that more than 200 ...

SAN DIEGO, Jan. 29, 2025 (GLOBE NEWSWIRE) -- Calidi Biotherapeutics Inc. (NYSE American: CLDI) (“Calidi”), a clinical-stage biotechnology company developing a new generation of targeted antitumor ...

To stay up to date on Akari’s recent developments on the Webull Corporate Connect Services Platform, current Webull users can follow AKTX from the app on their smartphone or table device. To download ...

Guo has not only been about software and assay development but also about identifying new drugs and new indications for existing drugs for the treatment of lung cancer and breast cancer. Through the ...

AngioDynamics, Inc. announced the commencement of the AMBITION BTK multicenter randomized controlled trial (RCT), which will ...

Pursuant to the terms of the securities purchase agreement, at the closing of the PIPE, Tectonic will issue an aggregate of 3,689,465 shares of common stock at a price of $50.00 per share to fund ...

AngioDynamics, Inc. (NASDAQ: ANGO), a leading and transformative medical technology company focused on restoring healthy blood flow in the body's vascular system, expanding cancer treatment options ...

SHM Converge 2025, SHM’s annual conference, is in Las Vegas this year from April 22 to April 25 and is definitely something ...